[
    "{\"step_by_step_thinking\": \"Document 0 provides a detailed account of a trial conducted to evaluate the efficacy of Cinpanemab in treating Parkinson's disease. The trial was stopped due to lack of efficacy. The changes in the MDS-UPDRS score, which is a measure of Parkinson's disease severity, were not significantly different between the control group and any of the Cinpanemab groups. This indicates that Cinpanemab did not have a significant effect on the progression of Parkinson's disease.\", \"answer_choice\": \"B\"}"
]